vs

Side-by-side financial comparison of BrightSpire Capital, Inc. (BRSP) and Neuronetics, Inc. (STIM). Click either name above to swap in a different company.

BrightSpire Capital, Inc. is the larger business by last-quarter revenue ($83.2M vs $41.8M, roughly 2.0× Neuronetics, Inc.). Neuronetics, Inc. runs the higher net margin — -17.2% vs -17.3%, a 0.0% gap on every dollar of revenue. On growth, Neuronetics, Inc. posted the faster year-over-year revenue change (85.7% vs -0.4%). BrightSpire Capital, Inc. produced more free cash flow last quarter ($55.1M vs $692.0K). Over the past eight quarters, Neuronetics, Inc.'s revenue compounded faster (54.9% CAGR vs -6.8%).

Oakley Capital Investments, is a large British investment trust focused on investments in mid-market companies in the business services, consumer, education and technology sectors. The company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.

Neuronetics is a Malvern, PA based, publicly traded company incorporated in Delaware in April 2003, that develops non-invasive treatments for psychiatric disorders that have shown resistance or lack of improvement using traditional medicine. The treatments are based upon neuromodulation technology. 

BRSP vs STIM — Head-to-Head

Bigger by revenue
BRSP
BRSP
2.0× larger
BRSP
$83.2M
$41.8M
STIM
Growing faster (revenue YoY)
STIM
STIM
+86.1% gap
STIM
85.7%
-0.4%
BRSP
Higher net margin
STIM
STIM
0.0% more per $
STIM
-17.2%
-17.3%
BRSP
More free cash flow
BRSP
BRSP
$54.4M more FCF
BRSP
$55.1M
$692.0K
STIM
Faster 2-yr revenue CAGR
STIM
STIM
Annualised
STIM
54.9%
-6.8%
BRSP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BRSP
BRSP
STIM
STIM
Revenue
$83.2M
$41.8M
Net Profit
$-14.4M
$-7.2M
Gross Margin
52.0%
Operating Margin
-12.1%
Net Margin
-17.3%
-17.2%
Revenue YoY
-0.4%
85.7%
Net Profit YoY
27.3%
43.2%
EPS (diluted)
$-0.11
$-0.10

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BRSP
BRSP
STIM
STIM
Q4 25
$83.2M
$41.8M
Q3 25
$83.9M
$37.3M
Q2 25
$85.9M
$38.1M
Q1 25
$77.6M
$32.0M
Q4 24
$83.5M
$22.5M
Q3 24
$88.2M
$18.5M
Q2 24
$91.4M
$16.4M
Q1 24
$95.8M
$17.4M
Net Profit
BRSP
BRSP
STIM
STIM
Q4 25
$-14.4M
$-7.2M
Q3 25
$984.0K
$-9.0M
Q2 25
$-23.1M
$-10.1M
Q1 25
$5.3M
$-12.7M
Q4 24
$-19.7M
$-12.7M
Q3 24
$12.7M
$-13.3M
Q2 24
$-67.9M
$-9.8M
Q1 24
$-57.1M
$-7.9M
Gross Margin
BRSP
BRSP
STIM
STIM
Q4 25
52.0%
Q3 25
45.9%
Q2 25
46.6%
Q1 25
49.2%
Q4 24
66.2%
Q3 24
75.6%
Q2 24
74.0%
Q1 24
75.1%
Operating Margin
BRSP
BRSP
STIM
STIM
Q4 25
-12.1%
Q3 25
-1.7%
-19.6%
Q2 25
-54.5%
-21.1%
Q1 25
5.1%
-34.4%
Q4 24
-24.9%
-51.0%
Q3 24
13.2%
-41.7%
Q2 24
-74.9%
-51.7%
Q1 24
-59.4%
-39.4%
Net Margin
BRSP
BRSP
STIM
STIM
Q4 25
-17.3%
-17.2%
Q3 25
1.2%
-24.3%
Q2 25
-26.9%
-26.6%
Q1 25
6.9%
-39.6%
Q4 24
-23.7%
-56.4%
Q3 24
14.4%
-72.0%
Q2 24
-74.2%
-59.8%
Q1 24
-59.6%
-45.2%
EPS (diluted)
BRSP
BRSP
STIM
STIM
Q4 25
$-0.11
$-0.10
Q3 25
$0.00
$-0.13
Q2 25
$-0.19
$-0.15
Q1 25
$0.04
$-0.21
Q4 24
$-0.16
$-0.34
Q3 24
$0.09
$-0.44
Q2 24
$-0.53
$-0.33
Q1 24
$-0.45
$-0.27

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BRSP
BRSP
STIM
STIM
Cash + ST InvestmentsLiquidity on hand
$66.8M
$28.1M
Total DebtLower is stronger
$2.5B
$65.8M
Stockholders' EquityBook value
$938.4M
$22.4M
Total Assets
$3.6B
$141.6M
Debt / EquityLower = less leverage
2.63×
2.94×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BRSP
BRSP
STIM
STIM
Q4 25
$66.8M
$28.1M
Q3 25
$113.4M
$28.0M
Q2 25
$154.3M
$11.0M
Q1 25
$200.9M
$20.2M
Q4 24
$302.2M
$18.5M
Q3 24
$263.8M
$20.9M
Q2 24
$203.3M
$42.6M
Q1 24
$221.5M
$47.7M
Total Debt
BRSP
BRSP
STIM
STIM
Q4 25
$2.5B
$65.8M
Q3 25
$2.2B
$65.7M
Q2 25
$2.3B
$55.5M
Q1 25
$2.3B
$55.3M
Q4 24
$2.5B
$55.2M
Q3 24
$2.6B
$46.0M
Q2 24
$2.5B
$59.8M
Q1 24
$2.6B
$59.4M
Stockholders' Equity
BRSP
BRSP
STIM
STIM
Q4 25
$938.4M
$22.4M
Q3 25
$976.4M
$27.4M
Q2 25
$994.4M
$27.1M
Q1 25
$1.0B
$35.5M
Q4 24
$1.0B
$27.7M
Q3 24
$1.1B
$9.4M
Q2 24
$1.1B
$19.4M
Q1 24
$1.2B
$27.7M
Total Assets
BRSP
BRSP
STIM
STIM
Q4 25
$3.6B
$141.6M
Q3 25
$3.3B
$145.5M
Q2 25
$3.4B
$134.7M
Q1 25
$3.6B
$142.0M
Q4 24
$3.7B
$140.9M
Q3 24
$3.8B
Q2 24
$3.8B
$96.8M
Q1 24
$3.9B
$103.8M
Debt / Equity
BRSP
BRSP
STIM
STIM
Q4 25
2.63×
2.94×
Q3 25
2.22×
2.40×
Q2 25
2.27×
2.05×
Q1 25
2.27×
1.56×
Q4 24
2.38×
1.99×
Q3 24
2.36×
4.90×
Q2 24
2.28×
3.08×
Q1 24
2.17×
2.15×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BRSP
BRSP
STIM
STIM
Operating Cash FlowLast quarter
$73.0M
$908.0K
Free Cash FlowOCF − Capex
$55.1M
$692.0K
FCF MarginFCF / Revenue
66.2%
1.7%
Capex IntensityCapex / Revenue
21.6%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$102.0M
$-21.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BRSP
BRSP
STIM
STIM
Q4 25
$73.0M
$908.0K
Q3 25
$29.9M
$-785.0K
Q2 25
$17.4M
$-3.5M
Q1 25
$10.5M
$-17.0M
Q4 24
$103.4M
$-8.6M
Q3 24
$31.3M
$-5.4M
Q2 24
$22.9M
$-5.0M
Q1 24
$24.6M
$-12.0M
Free Cash Flow
BRSP
BRSP
STIM
STIM
Q4 25
$55.1M
$692.0K
Q3 25
$27.4M
$-899.0K
Q2 25
$11.6M
$-3.8M
Q1 25
$8.0M
$-17.2M
Q4 24
$97.3M
$-8.7M
Q3 24
$28.3M
$-5.8M
Q2 24
$22.7M
$-5.6M
Q1 24
$22.2M
$-12.4M
FCF Margin
BRSP
BRSP
STIM
STIM
Q4 25
66.2%
1.7%
Q3 25
32.7%
-2.4%
Q2 25
13.4%
-9.9%
Q1 25
10.3%
-53.8%
Q4 24
116.6%
-38.6%
Q3 24
32.1%
-31.3%
Q2 24
24.9%
-34.0%
Q1 24
23.2%
-71.1%
Capex Intensity
BRSP
BRSP
STIM
STIM
Q4 25
21.6%
0.5%
Q3 25
2.9%
0.3%
Q2 25
6.8%
0.7%
Q1 25
3.2%
0.7%
Q4 24
7.3%
0.4%
Q3 24
3.4%
2.1%
Q2 24
0.1%
3.7%
Q1 24
2.5%
2.2%
Cash Conversion
BRSP
BRSP
STIM
STIM
Q4 25
Q3 25
30.36×
Q2 25
Q1 25
1.97×
Q4 24
Q3 24
2.46×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons